tiprankstipranks
Charles River Laboratories Intl (CRL)
NYSE:CRL

Charles River Labs (CRL) Ownership - Who Owns Charles River Labs?

500 Followers

Charles River Labs (CRL) Ownership Overview

2.81%34.81%25.23%37.16%
25.23% Other Institutional Investors
37.16% Public Companies and
Individual Investors
The ownership structure of Charles River Labs (CRL) stock is a mix of institutional, retail and individual investors. Approximately 60.04% of the company’s stock is owned by Institutional Investors, 2.81% is owned by Insiders and 37.16% is owned by Public Companies and Individual Investors.
The ownership structure of Charles River Labs (CRL) stock is a mix of institutional, retail and individual investors. Approximately 60.04% of the company’s stock is owned by Institutional Investors, 2.81% is owned by Insiders and 37.16% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
May 14, 2024
Joseph W Laplume
Evp, Corp Strategy & Develop
xxxxxxxxxxxxx
$295969
Mar 11, 2024
Michael Gunnar Knell
Csvp&chief Accounting Officer
xxxxxxxxxxxxx
$216156
Mar 05, 2024
Michael Gunnar Knell
Csvp&chief Accounting Officer
xxxxxxxxxxxxx
$717890
Mar 04, 2024
Shannon M Parisotto
Cevp, Disc & Safety Assessment
xxxxxxxxxxxxx
$959545

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2024
xxxxxxxxxxxxx
$298045
Mar 31, 2024
xxxxxxxxxxxxx
$4224652
Mar 31, 2024
xxxxxxxxxxxxx
$4546541
Mar 31, 2024
xxxxxxxxxxxxx
$6247836

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
6,073,153Institution11.79%1,325,404,911
5,415,802Institution10.51%1,181,944,628
2,319,918Institution4.50%506,298,904
1,817,597Institution3.53%396,672,369
1,000,401Institution1.94%218,327,514
962,056Institution1.87%209,959,101
932,807Institution1.81%203,575,800
815,195Institution1.58%177,908,157
815,169Institution1.58%177,902,533
624,600Institution1.21%136,312,704

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
6,073,153Institution11.79%1,325,404,911
1,000,401Institution1.94%218,327,514
962,056Institution1.87%209,959,101
815,195Institution1.58%177,908,157
624,600Institution1.21%136,312,704
437,830Institution0.85%95,552,019
416,053Institution0.81%90,799,407
369,327Institution0.72%80,601,924
336,269Institution0.65%73,387,347
332,146Institution0.64%72,487,543

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,637,193Institution3.18%338,211,330
1,323,868Institution2.57%273,484,651
1,294,837Institution2.51%267,487,427
727,913Institution1.41%150,372,268
613,807Institution1.19%134,165,934
613,807Institution1.19%134,165,934
552,985Institution1.07%120,683,446
537,046Institution1.04%117,204,919
377,163Institution0.73%82,440,289
376,574Institution0.73%82,183,510

FAQ

Who Owns Charles River Laboratories Intl (CRL)?
According to the latest TipRanks data, approximately 25.23% of the company's stock is held by institutional investors, 2.81% is held by insiders, and 37.16% is held by retail investors.
    What percentage of Charles River Laboratories Intl (CRL) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 25.23% of Charles River Laboratories Intl (CRL) stock is held by institutional investors.
      What percentage of Charles River Laboratories Intl (CRL) stock is held by retail investors?
      According to the latest TipRanks data, approximately 37.16% of Charles River Laboratories Intl (CRL) stock is held by retail investors.
        Who owns the most shares of Charles River Laboratories Intl (CRL)?
        VANGUARD INDEX FUNDS owns the most shares of Charles River Laboratories Intl (CRL).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis